Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki. The ...

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all ...

However, they revealed a deep-seated disagreement with co-founder and CEO Anne Wojcicki's strategic vision for the company. In her first on-the-record interview with Fortune since the mass ...

On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. 23andMe appointed three ...

Another Bay Area company has announced significant job cuts ahead of the holidays. Genetic testing firm 23andMe announced on ...

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. The new board members are Andre Fernandez, the former chief financial officer of WeWork ...